Team from Charité succeeds again in apparently fully eliminating HIV from a patient’s body
He went down in medical history: the “Berlin Patient,” the first person in the world to be cured of HIV, following a stem cell transplant at Charité –…
Deep metagenomic sequencing of wastewater in Berlin over 17 months shows this technique could help forecast disease outbreaks and monitor the spread of human pathogens. It can also reveal thousands of novel viruses, according to a study by the…
Researchers in Gary Lewin’s lab at the Max Delbrück Center have identified an ion channel that contributes to chronic pain, suggesting a new target for pain medication. The study was published in “Brain.”
The Max Delbrück Center, Berlin, celebrates its new, innovative research building with a “topping-out ceremony.” The Imaging Innovation Center, designed by the architectural firm heinlewischer, will host researchers specializing in imaging and…
Berlin-Brandenburg: an international start-up hotspot in the digital health segment
A team led by Prof. Dr. Han Sun from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has elucidated an important mechanism in the function of TREK channels at an atomic level. The results, published in the journal "Nature…
The European Molecular Biology Organization (EMBO) has elected Professor Claudia Langenberg of the Berlin Institute of Health at Charité (BIH), and of the Precision Healthcare University Research Institute (PHURI) at Queen Mary University of London,…
On July 8, the Max Delbrück Center and Bruker will kick off a strategic partnership to build a first-of-its-kind innovation hub for systems medicine. The new center will focus on the development and application of mass spectrometry based single-cell…
A new NMR spectrometer has been in operation at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) since the end of May. What makes it special is that it is based on a new type of ceramic high-temperature superconductor. Peter…
New approach to diminish antibiotic resistance developed by research team from Freie Universität Berlin, the Hebrew University of Jerusalem, and ETH Zurich
